PromarkerD is a blood test for diagnosing and predicting diabetic kidney disease.
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) attended the American Diabetes Association (ADA) 79th Scientific Sessions conference as a key opinion leader (KOL) on diabetic kidney disease diagnostics.
As part of American Diabetes Association (ADA) TV News Network, Proteomics International produced an informative video, including an update on PromarkerD.
For more information on PromarkerD, visit www.promarkerd.com/the-test/
